TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,760,724 | -51.1% | 210,613 | +45.3% | 0.00% | 0.0% |
| Q2 2023 | $3,601,205 | +80.1% | 144,976 | +9.0% | 0.00% | 0.0% |
| Q1 2023 | $1,999,974 | +486.0% | 132,977 | +361.0% | 0.00% | – |
| Q4 2022 | $341,272 | +61.7% | 28,848 | -19.0% | 0.00% | – |
| Q3 2022 | $211,000 | +6.6% | 35,593 | -23.4% | 0.00% | – |
| Q2 2022 | $198,000 | -81.7% | 46,446 | -59.1% | 0.00% | – |
| Q1 2022 | $1,080,000 | -59.9% | 113,461 | -20.0% | 0.00% | -100.0% |
| Q4 2021 | $2,695,000 | -14.1% | 141,811 | +50.5% | 0.00% | 0.0% |
| Q3 2021 | $3,136,000 | +19.0% | 94,202 | +38.7% | 0.00% | 0.0% |
| Q2 2021 | $2,635,000 | -54.9% | 67,908 | -43.9% | 0.00% | 0.0% |
| Q1 2021 | $5,837,000 | -30.5% | 121,082 | -25.0% | 0.00% | -50.0% |
| Q4 2020 | $8,396,000 | +136.0% | 161,412 | +21.4% | 0.00% | +100.0% |
| Q3 2020 | $3,558,000 | +41.9% | 132,983 | +3.3% | 0.00% | 0.0% |
| Q2 2020 | $2,508,000 | +316.6% | 128,762 | +110.3% | 0.00% | – |
| Q1 2020 | $602,000 | -49.2% | 61,215 | -42.6% | 0.00% | – |
| Q4 2019 | $1,185,000 | +173.0% | 106,700 | +38.4% | 0.00% | – |
| Q3 2019 | $434,000 | -10.9% | 77,070 | +36.8% | 0.00% | – |
| Q2 2019 | $487,000 | -16.3% | 56,331 | -22.2% | 0.00% | – |
| Q1 2019 | $582,000 | +85.9% | 72,411 | -5.1% | 0.00% | – |
| Q4 2018 | $313,000 | +26.2% | 76,300 | +73.2% | 0.00% | – |
| Q3 2018 | $248,000 | -97.9% | 44,046 | -95.0% | 0.00% | -100.0% |
| Q2 2018 | $11,686,000 | +1979.4% | 888,768 | +2148.1% | 0.00% | – |
| Q1 2018 | $562,000 | +95.8% | 39,535 | +12.7% | 0.00% | – |
| Q4 2017 | $287,000 | -55.3% | 35,075 | -35.2% | 0.00% | – |
| Q3 2017 | $642,000 | +16.3% | 54,141 | -1.4% | 0.00% | – |
| Q2 2017 | $552,000 | -14.6% | 54,922 | -1.1% | 0.00% | – |
| Q1 2017 | $646,000 | +5.7% | 55,529 | -57.7% | 0.00% | – |
| Q4 2016 | $611,000 | +336.4% | 131,268 | +624.3% | 0.00% | – |
| Q3 2016 | $140,000 | +26.1% | 18,123 | -1.4% | 0.00% | – |
| Q2 2016 | $111,000 | -37.6% | 18,375 | -12.2% | 0.00% | – |
| Q1 2016 | $178,000 | -29.9% | 20,924 | -1.6% | 0.00% | – |
| Q4 2015 | $254,000 | +70.5% | 21,261 | +43.2% | 0.00% | – |
| Q3 2015 | $149,000 | -17.7% | 14,847 | +36.2% | 0.00% | – |
| Q2 2015 | $181,000 | +31.2% | 10,900 | +22.9% | 0.00% | – |
| Q1 2015 | $138,000 | +56.8% | 8,870 | +59.6% | 0.00% | – |
| Q4 2014 | $88,000 | +175.0% | 5,557 | +87.9% | 0.00% | – |
| Q3 2014 | $32,000 | -5.9% | 2,958 | -16.7% | 0.00% | – |
| Q2 2014 | $34,000 | – | 3,549 | +88625.0% | 0.00% | – |
| Q1 2014 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q4 2013 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q3 2013 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q2 2013 | $0 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |